Lido Advisors LLC bought a new position in Cinemark Holdings, Inc. (NYSE:CNK - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 17,520 shares of the company's stock, valued at approximately $543,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. LPL Financial LLC grew its stake in shares of Cinemark by 6.8% in the fourth quarter. LPL Financial LLC now owns 8,722 shares of the company's stock worth $270,000 after acquiring an additional 556 shares during the last quarter. QRG Capital Management Inc. increased its stake in Cinemark by 3.2% during the fourth quarter. QRG Capital Management Inc. now owns 17,730 shares of the company's stock valued at $549,000 after acquiring an additional 557 shares during the period. Summit Investment Advisors Inc. lifted its position in shares of Cinemark by 5.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 11,546 shares of the company's stock worth $358,000 after acquiring an additional 618 shares during the period. Quarry LP grew its holdings in shares of Cinemark by 41.8% during the 4th quarter. Quarry LP now owns 2,114 shares of the company's stock worth $65,000 after purchasing an additional 623 shares in the last quarter. Finally, Sterling Capital Management LLC raised its stake in shares of Cinemark by 3.7% in the fourth quarter. Sterling Capital Management LLC now owns 18,339 shares of the company's stock valued at $568,000 after purchasing an additional 652 shares in the last quarter.
Cinemark Stock Up 1.3 %
Cinemark stock traded up $0.39 during mid-day trading on Wednesday, reaching $31.20. The company's stock had a trading volume of 2,954,364 shares, compared to its average volume of 3,012,860. The company has a market capitalization of $3.68 billion, a price-to-earnings ratio of 15.37 and a beta of 1.91. The business's 50 day simple moving average is $26.58 and its 200 day simple moving average is $29.35. The company has a debt-to-equity ratio of 3.28, a quick ratio of 0.96 and a current ratio of 1.01. Cinemark Holdings, Inc. has a 12 month low of $16.32 and a 12 month high of $36.28.
Cinemark (NYSE:CNK - Get Free Report) last issued its earnings results on Friday, May 2nd. The company reported ($0.32) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.32). The business had revenue of $540.70 million for the quarter, compared to the consensus estimate of $604.62 million. Cinemark had a net margin of 10.16% and a return on equity of 65.83%. The firm's revenue for the quarter was down 6.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 earnings per share. As a group, research analysts anticipate that Cinemark Holdings, Inc. will post 1.93 earnings per share for the current year.
Cinemark Announces Dividend
The firm also recently declared a -- dividend, which was paid on Wednesday, March 19th. Investors of record on Wednesday, March 5th were paid a $0.08 dividend. The ex-dividend date of this dividend was Wednesday, March 5th. Cinemark's dividend payout ratio (DPR) is presently 21.05%.
Insider Buying and Selling at Cinemark
In related news, insider Wanda Marie Gierhart sold 9,119 shares of Cinemark stock in a transaction dated Tuesday, February 25th. The shares were sold at an average price of $27.00, for a total transaction of $246,213.00. Following the completion of the sale, the insider now owns 147,414 shares of the company's stock, valued at approximately $3,980,178. The trade was a 5.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 2.10% of the company's stock.
Analysts Set New Price Targets
A number of analysts have weighed in on the company. Barrington Research reiterated an "outperform" rating and issued a $36.00 price target on shares of Cinemark in a research report on Monday. Wells Fargo & Company cut their target price on shares of Cinemark from $38.00 to $36.00 and set an "overweight" rating for the company in a research note on Wednesday, January 29th. Benchmark dropped their price target on Cinemark from $40.00 to $35.00 and set a "buy" rating for the company in a report on Thursday, February 20th. Macquarie restated an "outperform" rating and issued a $35.00 target price on shares of Cinemark in a research note on Thursday, February 20th. Finally, Wedbush restated a "neutral" rating and issued a $32.00 price objective on shares of Cinemark in a research report on Monday, April 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $32.80.
Get Our Latest Stock Analysis on Cinemark
Cinemark Company Profile
(
Free Report)
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
Featured Articles

Before you consider Cinemark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.
While Cinemark currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.